Review
Published on 24 Aug 2015
Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2015.00189
- 13,518 views
- 53 citations